Protein Buddy

Your first weeks on a GLP-1: what may change

A practical map of appetite, meals, protein and common gastrointestinal changes during the first weeks on Ozempic, Wegovy, Mounjaro or Zepbound.

3 min read
Four weekly calendar cards beside small meals and a water glass

What should I expect during the first weeks on a GLP-1 medication?

The first weeks vary. Some people notice reduced appetite quickly; others notice little at the starter dose. Nausea, diarrhea, constipation, fullness, fatigue or food aversions may occur, especially during initiation or dose escalation. Keep meals small, fluids regular and a simple record of symptoms and actual intake. Contact your prescriber for persistent, severe or worsening symptoms.

Key takeaways

  • There is no single first-week experience.
  • Starter periods are designed for treatment initiation, not for comparing rapid weight-loss results.
  • Gastrointestinal symptoms are often most noticeable during initiation or dose escalation.
  • Track actual intake and symptoms without changing the dose yourself.
  • A first-weeks hub should lead to food, nausea, hydration and protein guidance, not replace the prescriber.

There is no universal first week on a GLP-1. Some people notice appetite changes quickly, some mainly notice gastrointestinal symptoms, and some notice very little at the starter dose. The useful response is preparation and observation, not comparing your first seven days with somebody else's dramatic result.

Before the first dose

Set up the parts that remain useful whichever experience you have:

  • Read the medication guide and follow the administration instructions you were given.
  • Keep familiar small meals and drinks available.
  • Record a few normal days of food if you want a baseline.
  • Agree a protein goal with your clinician or dietitian.
  • Know how to contact the prescribing team.

What to set up before starting covers the baseline in more detail. Injection technique and dose changes belong to the manufacturer instructions and your healthcare team.

What may happen in days 1 to 3?

Appetite may fall, fullness may arrive earlier, or nothing obvious may happen. Nausea, diarrhea, constipation, abdominal discomfort or fatigue can occur. Official Zepbound and Wegovy information reports that gastrointestinal reactions are especially common during dose escalation.23

Use small familiar meals, eat slowly and keep fluids regular. Do not force a large meal to test whether you can still eat it.

What may happen in days 4 to 7?

Some people notice that appetite varies across the week. A change in hunger before the next dose does not tell you on its own whether treatment is working. Keep the scheduled plan and discuss a repeatable pattern with your prescriber rather than changing dose or timing yourself.

The nutrition question may become clearer here: once hunger is quieter, it is easy to skip a meal without noticing. Am I eating enough on a GLP-1? gives a four-signal check.

RecordWhy
Injection dayDate and timePlaces symptoms and appetite changes on a timeline
MealsWhat was actually finishedShows skipped meals and smaller portions
SymptomsType, timing and persistenceGives the prescribing team a clearer history
FluidsWhether normal drinking was possibleFlags when nausea, vomiting or diarrhea affect hydration
A first-weeks record should make patterns visible without pretending to diagnose them.

What changes in weeks 2 to 4?

The starter period is not a race to a target weight. Appetite and side effects may settle, continue or change. Food preferences may shift, and a meal that sounded good before treatment may suddenly feel unappealing. The joint advisory recommends flexibility, small regular meals and enough fluid rather than rigid menus.1

Use this period to find a small set of foods you can repeat:

  • One breakfast with protein.
  • One cold option for smell-sensitive days.
  • One drinkable option.
  • One simple dinner that can be halved and saved.
  • One fiber source that you tolerate.

How can Protein Buddy help?

Protein Buddy is a protein tracker for iPhone and Android that sets a personal daily protein goal and logs food by photo, voice, barcode or typing. Log what you actually eat against a clinician-agreed goal, then look at the weekly pattern instead of treating one low day as a verdict.

If the problem isUse this guide
No appetiteWhat to eat when you can barely eat
NauseaWhat to eat with GLP-1 nausea
Unsure about intakeAm I eating enough?
Protein targetHow much protein on a GLP-1
ConstipationFibre, fluids and protein

When should you contact your prescriber?

Contact the prescribing team for symptoms that are persistent, severe or worsening, repeated vomiting or diarrhea, inability to keep fluids down, marked weakness, or severe abdominal pain that does not go away. The official labels contain specific warnings that should take precedence over general food guidance.234

Do not raise, delay or stop a dose because of a timeline on this page. The timeline is for noticing patterns and knowing which questions to take to the clinician managing the medication.

More questions about GLP-1

How soon does a GLP-1 start working?

The timing varies. Some people notice appetite changes early and others notice little at the initial dose. Do not judge the whole treatment from one day or compare your first week with another person's result.

How much weight should I lose in the first week?

There is no required first-week amount. Early scale changes include fluid and normal day-to-day variation. Use the follow-up plan from your prescribing team rather than treating a social-media result as a target.

Why does my appetite return before the next dose?

People report different appetite patterns across the week, but a return of hunger does not by itself show that treatment failed. Do not change the dose or timing yourself. Record the pattern and discuss it with your prescriber.

What should I track in the first weeks?

A simple record can include injection day, appetite, nausea or bowel symptoms, fluids, meals actually finished and a clinician-agreed protein goal. The purpose is to see a pattern and support a clinical conversation, not to grade each day.

References
  1. Nutritional priorities to support GLP-1 therapy for obesity: a joint advisoryAmerican College of Lifestyle Medicine, American Society for Nutrition, Obesity Medicine Association and The Obesity Society, 2025
  2. Zepbound prescribing informationDailyMed, U.S. National Library of Medicine, 2026
  3. Wegovy prescribing informationDailyMed, U.S. National Library of Medicine, 2026
  4. Ozempic prescribing informationU.S. Food and Drug Administration, 2025
History of updates
Last checked First published Every article is re-read against its sources when we touch it. What that check covers is set out in our editorial standards.